Terns Pharmaceuticals, Inc. (TERN) Stock Competitors & Peer Comparison
See (TERN) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TERN | $52.95 | -0.03% | 4.8B | -51.41 | -$1.03 | N/A |
| VRTX | $476.25 | +2.03% | 118.9B | 27.79 | $16.85 | N/A |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| REGN | $628.48 | +2.61% | 63.7B | 15.08 | $40.99 | +0.59% |
| ARGX | $866.87 | -4.08% | 52.8B | 37.98 | $22.47 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $294.61 | +2.86% | 38.5B | 72.41 | $3.98 | N/A |
| RVMDW | $7.39 | +3.79% | 37.2B | N/A | N/A | N/A |
| RVMD | $169.27 | +2.09% | 36B | -23.84 | -$7.11 | N/A |
| MRNA | $61.71 | +3.99% | 24.2B | -7.49 | -$8.14 | N/A |
Stock Comparison
TERN vs VRTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, VRTX has a market cap of 118.9B. Regarding current trading prices, TERN is priced at $52.95, while VRTX trades at $476.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas VRTX's P/E ratio is 27.79. In terms of profitability, TERN's ROE is -0.20%, compared to VRTX's ROE of +0.24%. Regarding short-term risk, TERN is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check VRTX's competition here
TERN vs VRNA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, TERN is priced at $52.95, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas VRNA's P/E ratio is -102.80. In terms of profitability, TERN's ROE is -0.20%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, TERN is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check VRNA's competition here
TERN vs REGN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, REGN has a market cap of 63.7B. Regarding current trading prices, TERN is priced at $52.95, while REGN trades at $628.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas REGN's P/E ratio is 15.08. In terms of profitability, TERN's ROE is -0.20%, compared to REGN's ROE of +0.14%. Regarding short-term risk, TERN is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check REGN's competition here
TERN vs ARGX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ARGX has a market cap of 52.8B. Regarding current trading prices, TERN is priced at $52.95, while ARGX trades at $866.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ARGX's P/E ratio is 37.98. In terms of profitability, TERN's ROE is -0.20%, compared to ARGX's ROE of +0.37%. Regarding short-term risk, TERN is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ARGX's competition here
TERN vs SGEN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, TERN is priced at $52.95, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas SGEN's P/E ratio is -57.19. In terms of profitability, TERN's ROE is -0.20%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, TERN is less volatile compared to SGEN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check SGEN's competition here
TERN vs ALNY Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ALNY has a market cap of 38.5B. Regarding current trading prices, TERN is priced at $52.95, while ALNY trades at $294.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ALNY's P/E ratio is 72.41. In terms of profitability, TERN's ROE is -0.20%, compared to ALNY's ROE of +0.98%. Regarding short-term risk, TERN is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ALNY's competition here
TERN vs RVMDW Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RVMDW has a market cap of 37.2B. Regarding current trading prices, TERN is priced at $52.95, while RVMDW trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RVMDW's P/E ratio is N/A. In terms of profitability, TERN's ROE is -0.20%, compared to RVMDW's ROE of -0.83%. Regarding short-term risk, TERN is less volatile compared to RVMDW. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check RVMDW's competition here
TERN vs RVMD Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RVMD has a market cap of 36B. Regarding current trading prices, TERN is priced at $52.95, while RVMD trades at $169.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RVMD's P/E ratio is -23.84. In terms of profitability, TERN's ROE is -0.20%, compared to RVMD's ROE of -0.83%. Regarding short-term risk, TERN is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check RVMD's competition here
TERN vs MRNA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MRNA has a market cap of 24.2B. Regarding current trading prices, TERN is priced at $52.95, while MRNA trades at $61.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MRNA's P/E ratio is -7.49. In terms of profitability, TERN's ROE is -0.20%, compared to MRNA's ROE of -0.37%. Regarding short-term risk, TERN is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MRNA's competition here
TERN vs RPRX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RPRX has a market cap of 23.8B. Regarding current trading prices, TERN is priced at $52.95, while RPRX trades at $55.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RPRX's P/E ratio is 29.13. In terms of profitability, TERN's ROE is -0.20%, compared to RPRX's ROE of +0.13%. Regarding short-term risk, TERN is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check RPRX's competition here
TERN vs ROIV Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ROIV has a market cap of 23.2B. Regarding current trading prices, TERN is priced at $52.95, while ROIV trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ROIV's P/E ratio is -59.65. In terms of profitability, TERN's ROE is -0.20%, compared to ROIV's ROE of -0.07%. Regarding short-term risk, TERN is less volatile compared to ROIV. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ROIV's competition here
TERN vs UTHR Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, UTHR has a market cap of 23.1B. Regarding current trading prices, TERN is priced at $52.95, while UTHR trades at $554.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas UTHR's P/E ratio is 20.13. In terms of profitability, TERN's ROE is -0.20%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, TERN is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check UTHR's competition here
TERN vs BNTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BNTX has a market cap of 22.9B. Regarding current trading prices, TERN is priced at $52.95, while BNTX trades at $90.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BNTX's P/E ratio is -15.57. In terms of profitability, TERN's ROE is -0.20%, compared to BNTX's ROE of -0.07%. Regarding short-term risk, TERN is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check BNTX's competition here
TERN vs INSM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, INSM has a market cap of 22.1B. Regarding current trading prices, TERN is priced at $52.95, while INSM trades at $106.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas INSM's P/E ratio is -17.73. In terms of profitability, TERN's ROE is -0.20%, compared to INSM's ROE of -1.30%. Regarding short-term risk, TERN is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check INSM's competition here
TERN vs INCY Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, INCY has a market cap of 20.9B. Regarding current trading prices, TERN is priced at $52.95, while INCY trades at $108.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas INCY's P/E ratio is 14.03. In terms of profitability, TERN's ROE is -0.20%, compared to INCY's ROE of +0.29%. Regarding short-term risk, TERN is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check INCY's competition here
TERN vs BGNE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, TERN is priced at $52.95, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BGNE's P/E ratio is -22.55. In terms of profitability, TERN's ROE is -0.20%, compared to BGNE's ROE of +0.12%. Regarding short-term risk, TERN is less volatile compared to BGNE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check BGNE's competition here
TERN vs DNA-WT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, TERN is priced at $52.95, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, TERN's ROE is -0.20%, compared to DNA-WT's ROE of -0.57%. Regarding short-term risk, TERN is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check DNA-WT's competition here
TERN vs NBIX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, NBIX has a market cap of 16.2B. Regarding current trading prices, TERN is priced at $52.95, while NBIX trades at $167.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas NBIX's P/E ratio is 24.88. In terms of profitability, TERN's ROE is -0.20%, compared to NBIX's ROE of +0.22%. Regarding short-term risk, TERN is less volatile compared to NBIX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check NBIX's competition here
TERN vs GMAB Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, GMAB has a market cap of 15.9B. Regarding current trading prices, TERN is priced at $52.95, while GMAB trades at $26.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas GMAB's P/E ratio is 19.80. In terms of profitability, TERN's ROE is -0.20%, compared to GMAB's ROE of +0.15%. Regarding short-term risk, TERN is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check GMAB's competition here
TERN vs ASND Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ASND has a market cap of 14.8B. Regarding current trading prices, TERN is priced at $52.95, while ASND trades at $240.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ASND's P/E ratio is 27.14. In terms of profitability, TERN's ROE is -0.20%, compared to ASND's ROE of -56.42%. Regarding short-term risk, TERN is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ASND's competition here
TERN vs JAZZ Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, JAZZ has a market cap of 14.5B. Regarding current trading prices, TERN is priced at $52.95, while JAZZ trades at $233.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas JAZZ's P/E ratio is 2093.18. In terms of profitability, TERN's ROE is -0.20%, compared to JAZZ's ROE of +0.01%. Regarding short-term risk, TERN is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check JAZZ's competition here
TERN vs BBIO Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BBIO has a market cap of 13.4B. Regarding current trading prices, TERN is priced at $52.95, while BBIO trades at $70.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BBIO's P/E ratio is -18.35. In terms of profitability, TERN's ROE is -0.20%, compared to BBIO's ROE of +0.36%. Regarding short-term risk, TERN is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check BBIO's competition here
TERN vs EXEL Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, EXEL has a market cap of 12.9B. Regarding current trading prices, TERN is priced at $52.95, while EXEL trades at $52.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas EXEL's P/E ratio is 17.00. In terms of profitability, TERN's ROE is -0.20%, compared to EXEL's ROE of +0.40%. Regarding short-term risk, TERN is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check EXEL's competition here
TERN vs KRTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, TERN is priced at $52.95, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas KRTX's P/E ratio is -28.09. In terms of profitability, TERN's ROE is -0.20%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, TERN is less volatile compared to KRTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check KRTX's competition here
TERN vs IONS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, IONS has a market cap of 12.6B. Regarding current trading prices, TERN is priced at $52.95, while IONS trades at $77.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas IONS's P/E ratio is -37.81. In terms of profitability, TERN's ROE is -0.20%, compared to IONS's ROE of -0.59%. Regarding short-term risk, TERN is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check IONS's competition here
TERN vs AXSM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, AXSM has a market cap of 12.5B. Regarding current trading prices, TERN is priced at $52.95, while AXSM trades at $245.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas AXSM's P/E ratio is -64.87. In terms of profitability, TERN's ROE is -0.20%, compared to AXSM's ROE of -2.60%. Regarding short-term risk, TERN is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check AXSM's competition here
TERN vs MDGL Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MDGL has a market cap of 11.8B. Regarding current trading prices, TERN is priced at $52.95, while MDGL trades at $525.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MDGL's P/E ratio is -38.03. In terms of profitability, TERN's ROE is -0.20%, compared to MDGL's ROE of -0.50%. Regarding short-term risk, TERN is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MDGL's competition here
TERN vs RNAM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, TERN is priced at $52.95, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RNAM's P/E ratio is -17.39. In terms of profitability, TERN's ROE is -0.20%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, TERN is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check RNAM's competition here
TERN vs ARWR Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ARWR has a market cap of 11.3B. Regarding current trading prices, TERN is priced at $52.95, while ARWR trades at $81.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ARWR's P/E ratio is -35.20. In terms of profitability, TERN's ROE is -0.20%, compared to ARWR's ROE of -0.55%. Regarding short-term risk, TERN is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ARWR's competition here
TERN vs SMMT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, SMMT has a market cap of 11.1B. Regarding current trading prices, TERN is priced at $52.95, while SMMT trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas SMMT's P/E ratio is -8.96. In terms of profitability, TERN's ROE is -0.20%, compared to SMMT's ROE of -3.41%. Regarding short-term risk, TERN is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check SMMT's competition here
TERN vs BMRN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BMRN has a market cap of 10.9B. Regarding current trading prices, TERN is priced at $52.95, while BMRN trades at $57.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BMRN's P/E ratio is 40.65. In terms of profitability, TERN's ROE is -0.20%, compared to BMRN's ROE of +0.04%. Regarding short-term risk, TERN is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check BMRN's competition here
TERN vs KRYS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, KRYS has a market cap of 10B. Regarding current trading prices, TERN is priced at $52.95, while KRYS trades at $350.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas KRYS's P/E ratio is 45.48. In terms of profitability, TERN's ROE is -0.20%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, TERN is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check KRYS's competition here
TERN vs CYTK Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CYTK has a market cap of 10B. Regarding current trading prices, TERN is priced at $52.95, while CYTK trades at $81.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CYTK's P/E ratio is -11.66. In terms of profitability, TERN's ROE is -0.20%, compared to CYTK's ROE of +1.40%. Regarding short-term risk, TERN is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CYTK's competition here
TERN vs RXDX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, TERN is priced at $52.95, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RXDX's P/E ratio is -56.47. In terms of profitability, TERN's ROE is -0.20%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, TERN is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check RXDX's competition here
TERN vs NUVL Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, NUVL has a market cap of 9.1B. Regarding current trading prices, TERN is priced at $52.95, while NUVL trades at $123.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas NUVL's P/E ratio is -20.37. In terms of profitability, TERN's ROE is -0.20%, compared to NUVL's ROE of -0.43%. Regarding short-term risk, TERN is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check NUVL's competition here
TERN vs TECH Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, TECH has a market cap of 8.8B. Regarding current trading prices, TERN is priced at $52.95, while TECH trades at $59.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas TECH's P/E ratio is 80.37. In terms of profitability, TERN's ROE is -0.20%, compared to TECH's ROE of +0.05%. Regarding short-term risk, TERN is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check TECH's competition here
TERN vs IMGN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, TERN is priced at $52.95, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas IMGN's P/E ratio is -111.55. In terms of profitability, TERN's ROE is -0.20%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, TERN is less volatile compared to IMGN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check IMGN's competition here
TERN vs CORT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CORT has a market cap of 8.6B. Regarding current trading prices, TERN is priced at $52.95, while CORT trades at $81.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CORT's P/E ratio is 228.14. In terms of profitability, TERN's ROE is -0.20%, compared to CORT's ROE of +0.08%. Regarding short-term risk, TERN is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CORT's competition here
TERN vs BPMC Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, TERN is priced at $52.95, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BPMC's P/E ratio is -51.58. In terms of profitability, TERN's ROE is -0.20%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, TERN is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check BPMC's competition here
TERN vs HALO Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, HALO has a market cap of 8.3B. Regarding current trading prices, TERN is priced at $52.95, while HALO trades at $70.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas HALO's P/E ratio is 24.43. In terms of profitability, TERN's ROE is -0.20%, compared to HALO's ROE of +1.26%. Regarding short-term risk, TERN is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check HALO's competition here
TERN vs TGTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, TGTX has a market cap of 8.3B. Regarding current trading prices, TERN is priced at $52.95, while TGTX trades at $54.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas TGTX's P/E ratio is 18.54. In terms of profitability, TERN's ROE is -0.20%, compared to TGTX's ROE of +0.87%. Regarding short-term risk, TERN is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check TGTX's competition here
TERN vs APGE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, APGE has a market cap of 8.2B. Regarding current trading prices, TERN is priced at $52.95, while APGE trades at $132.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas APGE's P/E ratio is -30.69. In terms of profitability, TERN's ROE is -0.20%, compared to APGE's ROE of -0.33%. Regarding short-term risk, TERN is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check APGE's competition here
TERN vs CERE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, TERN is priced at $52.95, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CERE's P/E ratio is -16.47. In terms of profitability, TERN's ROE is -0.20%, compared to CERE's ROE of -0.72%. Regarding short-term risk, TERN is less volatile compared to CERE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CERE's competition here
TERN vs KYMR Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, KYMR has a market cap of 8.1B. Regarding current trading prices, TERN is priced at $52.95, while KYMR trades at $99.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas KYMR's P/E ratio is -27.44. In terms of profitability, TERN's ROE is -0.20%, compared to KYMR's ROE of -0.25%. Regarding short-term risk, TERN is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check KYMR's competition here
TERN vs ALKS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ALKS has a market cap of 8B. Regarding current trading prices, TERN is priced at $52.95, while ALKS trades at $51.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ALKS's P/E ratio is 53.41. In terms of profitability, TERN's ROE is -0.20%, compared to ALKS's ROE of +0.09%. Regarding short-term risk, TERN is less volatile compared to ALKS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ALKS's competition here
TERN vs IMVT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, IMVT has a market cap of 7.7B. Regarding current trading prices, TERN is priced at $52.95, while IMVT trades at $37.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas IMVT's P/E ratio is -13.58. In terms of profitability, TERN's ROE is -0.20%, compared to IMVT's ROE of -0.68%. Regarding short-term risk, TERN is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check IMVT's competition here
TERN vs IBRX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, IBRX has a market cap of 7.7B. Regarding current trading prices, TERN is priced at $52.95, while IBRX trades at $7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas IBRX's P/E ratio is -8.61. In terms of profitability, TERN's ROE is -0.20%, compared to IBRX's ROE of +1.39%. Regarding short-term risk, TERN is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check IBRX's competition here
TERN vs PTGX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, PTGX has a market cap of 7.7B. Regarding current trading prices, TERN is priced at $52.95, while PTGX trades at $120.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas PTGX's P/E ratio is -65.72. In terms of profitability, TERN's ROE is -0.20%, compared to PTGX's ROE of -0.18%. Regarding short-term risk, TERN is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check PTGX's competition here
TERN vs PCVX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, PCVX has a market cap of 7.5B. Regarding current trading prices, TERN is priced at $52.95, while PCVX trades at $53.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas PCVX's P/E ratio is -7.54. In terms of profitability, TERN's ROE is -0.20%, compared to PCVX's ROE of -0.33%. Regarding short-term risk, TERN is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check PCVX's competition here
TERN vs MTSR Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, TERN is priced at $52.95, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MTSR's P/E ratio is -23.58. In terms of profitability, TERN's ROE is -0.20%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, TERN is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MTSR's competition here
TERN vs RYTM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RYTM has a market cap of 7.3B. Regarding current trading prices, TERN is priced at $52.95, while RYTM trades at $110.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RYTM's P/E ratio is -33.93. In terms of profitability, TERN's ROE is -0.20%, compared to RYTM's ROE of -2.03%. Regarding short-term risk, TERN is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check RYTM's competition here
TERN vs MRUS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, TERN is priced at $52.95, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MRUS's P/E ratio is -17.05. In terms of profitability, TERN's ROE is -0.20%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, TERN is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check MRUS's competition here
TERN vs PTCT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, PTCT has a market cap of 6.8B. Regarding current trading prices, TERN is priced at $52.95, while PTCT trades at $83.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas PTCT's P/E ratio is -32.33. In terms of profitability, TERN's ROE is -0.20%, compared to PTCT's ROE of +1.00%. Regarding short-term risk, TERN is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check PTCT's competition here
TERN vs ACLX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, TERN is priced at $52.95, while ACLX trades at $115.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ACLX's P/E ratio is -28.27. In terms of profitability, TERN's ROE is -0.20%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, TERN is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check ACLX's competition here
TERN vs LQDA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, LQDA has a market cap of 6.6B. Regarding current trading prices, TERN is priced at $52.95, while LQDA trades at $73.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas LQDA's P/E ratio is 435.35. In terms of profitability, TERN's ROE is -0.20%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, TERN is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check LQDA's competition here
TERN vs RETA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, TERN is priced at $52.95, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RETA's P/E ratio is -66.29. In terms of profitability, TERN's ROE is -0.20%, compared to RETA's ROE of +0.47%. Regarding short-term risk, TERN is less volatile compared to RETA. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check RETA's competition here
TERN vs PRAX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, PRAX has a market cap of 6.5B. Regarding current trading prices, TERN is priced at $52.95, while PRAX trades at $311.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas PRAX's P/E ratio is -22.77. In terms of profitability, TERN's ROE is -0.20%, compared to PRAX's ROE of -0.43%. Regarding short-term risk, TERN is less volatile compared to PRAX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check PRAX's competition here
TERN vs ABVX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ABVX has a market cap of 6.5B. Regarding current trading prices, TERN is priced at $52.95, while ABVX trades at $93.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ABVX's P/E ratio is -18.40. In terms of profitability, TERN's ROE is -0.20%, compared to ABVX's ROE of -1.65%. Regarding short-term risk, TERN is less volatile compared to ABVX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ABVX's competition here
TERN vs CNTA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CNTA has a market cap of 6.3B. Regarding current trading prices, TERN is priced at $52.95, while CNTA trades at $40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CNTA's P/E ratio is -22.63. In terms of profitability, TERN's ROE is -0.20%, compared to CNTA's ROE of -0.60%. Regarding short-term risk, TERN is less volatile compared to CNTA. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CNTA's competition here
TERN vs COGT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, COGT has a market cap of 6.2B. Regarding current trading prices, TERN is priced at $52.95, while COGT trades at $37.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas COGT's P/E ratio is -16.73. In terms of profitability, TERN's ROE is -0.20%, compared to COGT's ROE of -0.83%. Regarding short-term risk, TERN is less volatile compared to COGT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check COGT's competition here
TERN vs SRRK Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, SRRK has a market cap of 6.1B. Regarding current trading prices, TERN is priced at $52.95, while SRRK trades at $52.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas SRRK's P/E ratio is -14.82. In terms of profitability, TERN's ROE is -0.20%, compared to SRRK's ROE of -1.64%. Regarding short-term risk, TERN is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check SRRK's competition here
TERN vs SYRE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, SYRE has a market cap of 5.9B. Regarding current trading prices, TERN is priced at $52.95, while SYRE trades at $87.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas SYRE's P/E ratio is -45.78. In terms of profitability, TERN's ROE is -0.20%, compared to SYRE's ROE of -0.31%. Regarding short-term risk, TERN is less volatile compared to SYRE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check SYRE's competition here
TERN vs BLTE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, BLTE has a market cap of 5.8B. Regarding current trading prices, TERN is priced at $52.95, while BLTE trades at $145.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas BLTE's P/E ratio is -57.12. In terms of profitability, TERN's ROE is -0.20%, compared to BLTE's ROE of -0.27%. Regarding short-term risk, TERN is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check BLTE's competition here
TERN vs CGON Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CGON has a market cap of 5.8B. Regarding current trading prices, TERN is priced at $52.95, while CGON trades at $67.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CGON's P/E ratio is -28.09. In terms of profitability, TERN's ROE is -0.20%, compared to CGON's ROE of -0.23%. Regarding short-term risk, TERN is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CGON's competition here
TERN vs CDTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, TERN is priced at $52.95, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CDTX's P/E ratio is -19.77. In terms of profitability, TERN's ROE is -0.20%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, TERN is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check CDTX's competition here
TERN vs LGND Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, LGND has a market cap of 5.6B. Regarding current trading prices, TERN is priced at $52.95, while LGND trades at $283.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas LGND's P/E ratio is 36.29. In terms of profitability, TERN's ROE is -0.20%, compared to LGND's ROE of +0.16%. Regarding short-term risk, TERN is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check LGND's competition here
TERN vs MIRM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MIRM has a market cap of 5.6B. Regarding current trading prices, TERN is priced at $52.95, while MIRM trades at $111.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MIRM's P/E ratio is -8.15. In terms of profitability, TERN's ROE is -0.20%, compared to MIRM's ROE of -2.89%. Regarding short-term risk, TERN is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MIRM's competition here
TERN vs ABCM Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, TERN is priced at $52.95, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, TERN's ROE is -0.20%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, TERN is less volatile compared to ABCM. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ABCM's competition here
TERN vs ISEE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, TERN is priced at $52.95, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ISEE's P/E ratio is -22.44. In terms of profitability, TERN's ROE is -0.20%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, TERN is less volatile compared to ISEE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ISEE's competition here
TERN vs LEGN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, LEGN has a market cap of 5.4B. Regarding current trading prices, TERN is priced at $52.95, while LEGN trades at $29.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas LEGN's P/E ratio is -21.23. In terms of profitability, TERN's ROE is -0.20%, compared to LEGN's ROE of -0.25%. Regarding short-term risk, TERN is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check LEGN's competition here
TERN vs FBIOX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, FBIOX has a market cap of 5.3B. Regarding current trading prices, TERN is priced at $52.95, while FBIOX trades at $26.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas FBIOX's P/E ratio is N/A. In terms of profitability, TERN's ROE is -0.20%, compared to FBIOX's ROE of N/A. Regarding short-term risk, TERN is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check FBIOX's competition here
TERN vs APLS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, APLS has a market cap of 5.3B. Regarding current trading prices, TERN is priced at $52.95, while APLS trades at $41.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas APLS's P/E ratio is 38.35. In terms of profitability, TERN's ROE is -0.20%, compared to APLS's ROE of +0.40%. Regarding short-term risk, TERN is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check APLS's competition here
TERN vs CRSP Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CRSP has a market cap of 5.2B. Regarding current trading prices, TERN is priced at $52.95, while CRSP trades at $55.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CRSP's P/E ratio is -8.75. In terms of profitability, TERN's ROE is -0.20%, compared to CRSP's ROE of -0.31%. Regarding short-term risk, TERN is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CRSP's competition here
TERN vs TVTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, TVTX has a market cap of 5.2B. Regarding current trading prices, TERN is priced at $52.95, while TVTX trades at $56.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas TVTX's P/E ratio is -111.90. In terms of profitability, TERN's ROE is -0.20%, compared to TVTX's ROE of -0.27%. Regarding short-term risk, TERN is less volatile compared to TVTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check TVTX's competition here
TERN vs CAI Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CAI has a market cap of 5B. Regarding current trading prices, TERN is priced at $52.95, while CAI trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CAI's P/E ratio is -6.37. In terms of profitability, TERN's ROE is -0.20%, compared to CAI's ROE of +0.06%. Regarding short-term risk, TERN is less volatile compared to CAI. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CAI's competition here
TERN vs ERAS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ERAS has a market cap of 4.7B. Regarding current trading prices, TERN is priced at $52.95, while ERAS trades at $15.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ERAS's P/E ratio is -16.20. In terms of profitability, TERN's ROE is -0.20%, compared to ERAS's ROE of -0.77%. Regarding short-term risk, TERN is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ERAS's competition here
TERN vs FOLD Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, TERN is priced at $52.95, while FOLD trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas FOLD's P/E ratio is -161.00. In terms of profitability, TERN's ROE is -0.20%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, TERN is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check FOLD's competition here
TERN vs AKRO Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, TERN is priced at $52.95, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas AKRO's P/E ratio is -14.57. In terms of profitability, TERN's ROE is -0.20%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, TERN is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check AKRO's competition here
TERN vs KNSA Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, KNSA has a market cap of 4.5B. Regarding current trading prices, TERN is priced at $52.95, while KNSA trades at $60.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas KNSA's P/E ratio is 65.37. In terms of profitability, TERN's ROE is -0.20%, compared to KNSA's ROE of +0.13%. Regarding short-term risk, TERN is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check KNSA's competition here
TERN vs ALPN Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, TERN is priced at $52.95, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ALPN's P/E ratio is -101.52. In terms of profitability, TERN's ROE is -0.20%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, TERN is less volatile compared to ALPN. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ALPN's competition here
TERN vs CELC Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CELC has a market cap of 4.4B. Regarding current trading prices, TERN is priced at $52.95, while CELC trades at $95.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CELC's P/E ratio is -23.13. In terms of profitability, TERN's ROE is -0.20%, compared to CELC's ROE of -2.45%. Regarding short-term risk, TERN is less volatile compared to CELC. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CELC's competition here
TERN vs MANE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MANE has a market cap of 4.3B. Regarding current trading prices, TERN is priced at $52.95, while MANE trades at $109.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MANE's P/E ratio is -39.08. In terms of profitability, TERN's ROE is -0.20%, compared to MANE's ROE of -0.95%. Regarding short-term risk, TERN is less volatile compared to MANE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MANE's competition here
TERN vs XENE Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, XENE has a market cap of 4.3B. Regarding current trading prices, TERN is priced at $52.95, while XENE trades at $55.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas XENE's P/E ratio is -11.62. In terms of profitability, TERN's ROE is -0.20%, compared to XENE's ROE of -0.49%. Regarding short-term risk, TERN is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check XENE's competition here
TERN vs VCYT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, VCYT has a market cap of 4.3B. Regarding current trading prices, TERN is priced at $52.95, while VCYT trades at $57.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas VCYT's P/E ratio is 49.81. In terms of profitability, TERN's ROE is -0.20%, compared to VCYT's ROE of +0.07%. Regarding short-term risk, TERN is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check VCYT's competition here
TERN vs OPT Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, TERN is priced at $52.95, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas OPT's P/E ratio is -1.52. In terms of profitability, TERN's ROE is -0.20%, compared to OPT's ROE of +1.09%. Regarding short-term risk, TERN is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check OPT's competition here
TERN vs EWTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, EWTX has a market cap of 4.2B. Regarding current trading prices, TERN is priced at $52.95, while EWTX trades at $39.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas EWTX's P/E ratio is -23.39. In terms of profitability, TERN's ROE is -0.20%, compared to EWTX's ROE of -0.33%. Regarding short-term risk, TERN is less volatile compared to EWTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check EWTX's competition here
TERN vs MRTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, TERN is priced at $52.95, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas MRTX's P/E ratio is -4.82. In terms of profitability, TERN's ROE is -0.20%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, TERN is less volatile compared to MRTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check MRTX's competition here
TERN vs VKTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, VKTX has a market cap of 4B. Regarding current trading prices, TERN is priced at $52.95, while VKTX trades at $36.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas VKTX's P/E ratio is -8.39. In terms of profitability, TERN's ROE is -0.20%, compared to VKTX's ROE of -0.71%. Regarding short-term risk, TERN is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check VKTX's competition here
TERN vs DFTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, DFTX has a market cap of 3.9B. Regarding current trading prices, TERN is priced at $52.95, while DFTX trades at $42.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas DFTX's P/E ratio is N/A. In terms of profitability, TERN's ROE is -0.20%, compared to DFTX's ROE of -1.02%. Regarding short-term risk, TERN is less volatile compared to DFTX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check DFTX's competition here
TERN vs DNLI Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, DNLI has a market cap of 3.9B. Regarding current trading prices, TERN is priced at $52.95, while DNLI trades at $25.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas DNLI's P/E ratio is -8.60. In terms of profitability, TERN's ROE is -0.20%, compared to DNLI's ROE of -0.52%. Regarding short-term risk, TERN is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check DNLI's competition here
TERN vs ACAD Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, ACAD has a market cap of 3.9B. Regarding current trading prices, TERN is priced at $52.95, while ACAD trades at $23.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas ACAD's P/E ratio is 10.23. In terms of profitability, TERN's ROE is -0.20%, compared to ACAD's ROE of +0.36%. Regarding short-term risk, TERN is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check ACAD's competition here
TERN vs CPRX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CPRX has a market cap of 3.8B. Regarding current trading prices, TERN is priced at $52.95, while CPRX trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CPRX's P/E ratio is 18.15. In terms of profitability, TERN's ROE is -0.20%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, TERN is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CPRX's competition here
TERN vs CRNX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CRNX has a market cap of 3.8B. Regarding current trading prices, TERN is priced at $52.95, while CRNX trades at $37.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CRNX's P/E ratio is -6.99. In terms of profitability, TERN's ROE is -0.20%, compared to CRNX's ROE of -0.44%. Regarding short-term risk, TERN is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CRNX's competition here
TERN vs RYZB Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, TERN is priced at $52.95, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas RYZB's P/E ratio is -57.86. In terms of profitability, TERN's ROE is -0.20%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, TERN is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check RYZB's competition here
TERN vs CBAY Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, TERN is priced at $52.95, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas CBAY's P/E ratio is -32.81. In terms of profitability, TERN's ROE is -0.20%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, TERN is less volatile compared to CBAY. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check CBAY's competition here
TERN vs NAMS Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, NAMS has a market cap of 3.7B. Regarding current trading prices, TERN is priced at $52.95, while NAMS trades at $32.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas NAMS's P/E ratio is -17.64. In terms of profitability, TERN's ROE is -0.20%, compared to NAMS's ROE of -0.30%. Regarding short-term risk, TERN is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check NAMS's competition here
TERN vs DNTH Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, DNTH has a market cap of 3.7B. Regarding current trading prices, TERN is priced at $52.95, while DNTH trades at $90.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas DNTH's P/E ratio is -20.69. In terms of profitability, TERN's ROE is -0.20%, compared to DNTH's ROE of -0.02%. Regarding short-term risk, TERN is less volatile compared to DNTH. This indicates potentially lower risk in terms of short-term price fluctuations for TERN.Check DNTH's competition here
TERN vs NAMSW Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, NAMSW has a market cap of 3.6B. Regarding current trading prices, TERN is priced at $52.95, while NAMSW trades at $18.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas NAMSW's P/E ratio is N/A. In terms of profitability, TERN's ROE is -0.20%, compared to NAMSW's ROE of -0.30%. Regarding short-term risk, TERN is more volatile compared to NAMSW. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check NAMSW's competition here
TERN vs SWTX Comparison June 2026
TERN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TERN stands at 4.8B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, TERN is priced at $52.95, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TERN currently has a P/E ratio of -51.41, whereas SWTX's P/E ratio is -13.78. In terms of profitability, TERN's ROE is -0.20%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, TERN is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for TERN.Check SWTX's competition here